700 related articles for article (PubMed ID: 12833123)
1. Receptor targeting of adeno-associated virus vectors.
Büning H; Ried MU; Perabo L; Gerner FM; Huttner NA; Enssle J; Hallek M
Gene Ther; 2003 Jul; 10(14):1142-51. PubMed ID: 12833123
[TBL] [Abstract][Full Text] [Related]
2. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
3. Recent developments in adeno-associated virus vector technology.
Büning H; Perabo L; Coutelle O; Quadt-Humme S; Hallek M
J Gene Med; 2008 Jul; 10(7):717-33. PubMed ID: 18452237
[TBL] [Abstract][Full Text] [Related]
4. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
[TBL] [Abstract][Full Text] [Related]
5. Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells.
Nicklin SA; Buening H; Dishart KL; de Alwis M; Girod A; Hacker U; Thrasher AJ; Ali RR; Hallek M; Baker AH
Mol Ther; 2001 Sep; 4(3):174-81. PubMed ID: 11545607
[TBL] [Abstract][Full Text] [Related]
6. Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors.
Müller OJ; Kaul F; Weitzman MD; Pasqualini R; Arap W; Kleinschmidt JA; Trepel M
Nat Biotechnol; 2003 Sep; 21(9):1040-6. PubMed ID: 12897791
[TBL] [Abstract][Full Text] [Related]
7. Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo.
Shevtsova Z; Malik JM; Michel U; Bähr M; Kügler S
Exp Physiol; 2005 Jan; 90(1):53-9. PubMed ID: 15542619
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy progress and prospects--vectorology: design and production of expression cassettes in AAV vectors.
Le Bec C; Douar AM
Gene Ther; 2006 May; 13(10):805-13. PubMed ID: 16453010
[TBL] [Abstract][Full Text] [Related]
9. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge.
Zaiss AK; Muruve DA
Gene Ther; 2008 Jun; 15(11):808-16. PubMed ID: 18385765
[TBL] [Abstract][Full Text] [Related]
10. Selective gene expression in brain microglia mediated via adeno-associated virus type 2 and type 5 vectors.
Cucchiarini M; Ren XL; Perides G; Terwilliger EF
Gene Ther; 2003 Apr; 10(8):657-67. PubMed ID: 12692594
[TBL] [Abstract][Full Text] [Related]
11. Mosaic vectors comprised of modified AAV1 capsid proteins for efficient vector purification and targeting to vascular endothelial cells.
Stachler MD; Bartlett JS
Gene Ther; 2006 Jun; 13(11):926-31. PubMed ID: 16482202
[TBL] [Abstract][Full Text] [Related]
12. Engineering adeno-associated virus serotype 2-based targeting vectors using a new insertion site-position 453-and single point mutations.
Boucas J; Lux K; Huber A; Schievenbusch S; von Freyend MJ; Perabo L; Quadt-Humme S; Odenthal M; Hallek M; Büning H
J Gene Med; 2009 Dec; 11(12):1103-13. PubMed ID: 19777441
[TBL] [Abstract][Full Text] [Related]
13. Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo.
Zhong L; Chen L; Li Y; Qing K; Weigel-Kelley KA; Chan RJ; Yoder MC; Srivastava A
Mol Ther; 2004 Nov; 10(5):950-7. PubMed ID: 15509512
[TBL] [Abstract][Full Text] [Related]
14. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
[TBL] [Abstract][Full Text] [Related]
15. Adeno-associated virus serotypes: vector toolkit for human gene therapy.
Wu Z; Asokan A; Samulski RJ
Mol Ther; 2006 Sep; 14(3):316-27. PubMed ID: 16824801
[TBL] [Abstract][Full Text] [Related]
16. Strategies for improving the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivo.
Jayandharan GR; Zhong L; Li B; Kachniarz B; Srivastava A
Gene Ther; 2008 Sep; 15(18):1287-93. PubMed ID: 18496572
[TBL] [Abstract][Full Text] [Related]
17. Targeting the heart with gene therapy-optimized gene delivery methods.
Müller OJ; Katus HA; Bekeredjian R
Cardiovasc Res; 2007 Feb; 73(3):453-62. PubMed ID: 17097076
[TBL] [Abstract][Full Text] [Related]
18. Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo.
Palomeque J; Chemaly ER; Colosi P; Wellman JA; Zhou S; Del Monte F; Hajjar RJ
Gene Ther; 2007 Jul; 14(13):989-97. PubMed ID: 17251988
[TBL] [Abstract][Full Text] [Related]
19. Clinical gene therapy using recombinant adeno-associated virus vectors.
Mueller C; Flotte TR
Gene Ther; 2008 Jun; 15(11):858-63. PubMed ID: 18418415
[TBL] [Abstract][Full Text] [Related]
20. Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver.
Loiler SA; Conlon TJ; Song S; Tang Q; Warrington KH; Agarwal A; Kapturczak M; Li C; Ricordi C; Atkinson MA; Muzyczka N; Flotte TR
Gene Ther; 2003 Sep; 10(18):1551-8. PubMed ID: 12907946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]